Literature DB >> 22830445

DrugLogit: logistic discrimination between drugs and nondrugs including disease-specificity by assigning probabilities based on molecular properties.

Alfonso T García-Sosa1, Mare Oja, Csaba Hetényi, Uko Maran.   

Abstract

The increasing knowledge of both structure and activity of compounds provides a good basis for enhancing the pharmacological characterization of chemical libraries. In addition, pharmacology can be seen as incorporating both advances from molecular biology as well as chemical sciences, with innovative insight provided from studying target-ligand data from a ligand molecular point of view. Predictions and profiling of libraries of drug candidates have previously focused mainly on certain cases of oral bioavailability. Inclusion of other administration routes and disease-specificity would improve the precision of drug profiling. In this work, recent data are extended, and a probability-based approach is introduced for quantitative and gradual classification of compounds into categories of drugs/nondrugs, as well as for disease- or organ-specificity. Using experimental data of over 1067 compounds and multivariate logistic regressions, the classification shows good performance in training and independent test cases. The regressions have high statistical significance in terms of the robustness of coefficients and 95% confidence intervals provided by a 1000-fold bootstrapping resampling. Besides their good predictive power, the classification functions remain chemically interpretable, containing only one to five variables in total, and the physicochemical terms involved can be easily calculated. The present approach is useful for an improved description and filtering of compound libraries. It can also be applied sequentially or in combinations of filters, as well as adapted to particular use cases. The scores and equations may be able to suggest possible routes for compound or library modification. The data is made available for reuse by others, and the equations are freely accessible at http://hermes.chem.ut.ee/~alfx/druglogit.html.

Mesh:

Substances:

Year:  2012        PMID: 22830445     DOI: 10.1021/ci200587h

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  10 in total

1.  Predicting protein-ligand affinity with a random matrix framework.

Authors:  Alpha A Lee; Michael P Brenner; Lucy J Colwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

2.  Distinguishing drug/non-drug-like small molecules in drug discovery using deep belief network.

Authors:  Seyed Aghil Hooshmand; Sadegh Azimzadeh Jamalkandi; Seyed Mehdi Alavi; Ali Masoudi-Nejad
Journal:  Mol Divers       Date:  2020-03-19       Impact factor: 2.943

3.  MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development.

Authors:  Selcuk Korkmaz; Gokmen Zararsiz; Dincer Goksuluk
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

4.  Peptide-ligand binding modeling of siRNA with cell-penetrating peptides.

Authors:  Alfonso T García-Sosa; Indrek Tulp; Kent Langel; Ülo Langel
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

5.  Indexing Natural Products for Their Potential Anti-Diabetic Activity: Filtering and Mapping Discriminative Physicochemical Properties.

Authors:  Mouhammad Zeidan; Mahmoud Rayan; Nuha Zeidan; Mizied Falah; Anwar Rayan
Journal:  Molecules       Date:  2017-09-17       Impact factor: 4.411

6.  Drug-Target Interaction Prediction through Label Propagation with Linear Neighborhood Information.

Authors:  Wen Zhang; Yanlin Chen; Dingfang Li
Journal:  Molecules       Date:  2017-11-25       Impact factor: 4.411

7.  Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.

Authors:  Madhu Sudhana Saddala; Anton Lennikov; Hu Huang
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

8.  Drug-Target Interaction Prediction via Dual Laplacian Graph Regularized Logistic Matrix Factorization.

Authors:  Aizhen Wang; Minhui Wang
Journal:  Biomed Res Int       Date:  2021-03-26       Impact factor: 3.411

9.  Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.

Authors:  Haeseung Lee; Seungmin Kang; Wankyu Kim
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

10.  Data Mining and Machine Learning Models for Predicting Drug Likeness and Their Disease or Organ Category.

Authors:  Abraham Yosipof; Rita C Guedes; Alfonso T García-Sosa
Journal:  Front Chem       Date:  2018-05-09       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.